BioMarin Pharmaceuticals

BioMarin Pharmaceuticals is a biopharmaceutical company that focuses on developing innovative medicines for people with rare genetic disorders. Founded in 1997, it specializes in treatments that address specific conditions, particularly those affecting children. BioMarin’s therapies often involve advanced biotechnology and aim to improve patients' quality of life. The company's portfolio includes medications for diseases like phenylketonuria (PKU) and various forms of mucopolysaccharidosis (MPS). By prioritizing rare diseases, BioMarin plays a crucial role in providing solutions for patients with limited treatment options.